Holders — by stockHoldings — by fund
SUPERSTRING CAPITAL MANAGEMENT LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001931118
$158.4M
disclosed book value
32
positions
8.4%
largest position share
Positions, as of 2026-06-30
top 32 of 32 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | COGTCOGENT BIOSCIENCES INC | 343,284 | $13.3M | 8.4% |
| 2 | AXSMAXSOME THERAPEUTICS INC. | 53,916 | $13.2M | 8.3% |
| 3 | GMABGENMAB A/S | 430,600 | $11.8M | 7.5% |
| 4 | CLDXCELLDEX THERAPEUTICS INC NEW | 287,583 | $10.7M | 6.8% |
| 5 | TRVITREVI THERAPEUTICS INC | 524,224 | $9.8M | 6.2% |
| 6 | RVMDREVOLUTION MEDICINES INC | 51,053 | $9.6M | 6% |
| 7 | DFTXDEFINIUM THERAPEUTICS INC | 188,282 | $8.9M | 5.6% |
| 8 | VIRVIR BIOTECHNOLOGY INC | 853,685 | $8.7M | 5.5% |
| 9 | IMVTIMMUNOVANT INC | 208,368 | $8.0M | 5.1% |
| 10 | UROGEN PHARMA LTD | 191,313 | $7.0M | 4.4% |
| 11 | CLYMCLIMB BIO INC | 521,082 | $6.8M | 4.3% |
| 12 | ANLADLAI NORTYE LTD | 552,501 | $6.4M | 4% |
| 13 | SVRASAVARA INC | 977,460 | $6.0M | 3.8% |
| 14 | MPLTMAPLIGHT THERAPEUTICS INC | 125,432 | $4.5M | 2.8% |
| 15 | ORICORIC PHARMACEUTICALS INC | 406,077 | $4.4M | 2.8% |
| 16 | UTHRUNITED THERAPEUTICS CORP DEL | 7,172 | $3.9M | 2.5% |
| 17 | PCVXVAXCYTE INC | 66,793 | $3.9M | 2.5% |
| 18 | ONCBEONE MEDICINES LTD | 12,273 | $3.5M | 2.2% |
| 19 | CABACABALETTA BIO INC | 1.3M | $3.5M | 2.2% |
| 20 | ZLABZAI LAB LTD | 155,813 | $3.0M | 1.9% |
| 21 | SIONSIONNA THERAPEUTICS INC | 63,156 | $2.8M | 1.8% |
| 22 | DRUGBRIGHT MINDS BIOSCIENCES INC | 30,456 | $2.1M | 1.3% |
| 23 | ACRSACLARIS THERAPEUTICS INC | 257,675 | $1.4M | 0.9% |
| 24 | HELPCYBIN INC | 204,424 | $1.4M | 0.9% |
| 25 | KINIKSA PHARMACEUTICALS INTL | 18,867 | $1.2M | 0.8% |
| 26 | ROIVANT SCIENCES LTD | 25,623 | $906,798 | 0.6% |
| 27 | TNXPTONIX PHARMACEUTICALS HLDG C | 63,648 | $812,148 | 0.5% |
| 28 | TARAPROTARA THERAPEUTICS INC | 121,457 | $463,966 | 0.3% |
| 29 | FTHFAETH THERAPEUTICS INC | 14,175 | $354,375 | 0.2% |
| 30 | BOLDBOUNDLESS BIO INC | 55,356 | $138,390 | 0.1% |
| 31 | BMEABIOMEA FUSION INC | 250,000 | $85,306 | 0.1% |
| 32 | MNLOUSDVYNE THERAPEUTICS INC | 61,269 | $39,868 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.